While cancer immunotherapy has made a giant leap in the past five years, the majority of therapies at advanced stages of development are clustered in .. Read more a similar target space. The increased investment in immuno-oncology has created an urgent opportunity to discover and populate new target spaces that either present new classes of immunotherapies or can be used in combination with existing products. Cambridge Healthtech Institute’s Fourth Annual Emerging Targets for Immunomodulatory Antibodies and Combinations conference will cover the emerging target space, including immunomodulatory inhibitor and agonist targets, stromal and immune cell targets, and strategies for rational combination immunotherapy. Case studies of preclinical and translational approaches to the discovery and validation of new immuno-oncology targets and combinations will be presented.
- Share your Experience
More Events From The Organizer
- Automated Multi-Attribute Meth..22 Sep 2020Online